Algernon Pharmaceuticals Inc. - Warrants
Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on advancing its lead compounds for non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough.
Algernon Pharmaceuticals Inc. - Warrants (AGN.WT)
le 1 novembre /November 2019
Algernon Pharmaceutical Inc. - Warrants (the "Warrants") have been approved for listing.
Each Warrant entitles the holder thereof, upon exercise, together with the payment of the Exercise price of $0.12 before the Time of Expiry, subject to acceleration to acquire one Common share.
See the Warrant Indenture for full details.